BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12954816)

  • 1. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
    Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K
    J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
    Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
    Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
    Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501.
    Urwyler S; Mosbacher J; Lingenhoehl K; Heid J; Hofstetter K; Froestl W; Bettler B; Kaupmann K
    Mol Pharmacol; 2001 Nov; 60(5):963-71. PubMed ID: 11641424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes.
    Mannoury la Cour C; Herbelles C; Pasteau V; de Nanteuil G; Millan MJ
    J Neurochem; 2008 Apr; 105(2):308-23. PubMed ID: 18021295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.
    Gjoni T; Urwyler S
    Eur J Pharmacol; 2009 Jan; 603(1-3):37-41. PubMed ID: 19109945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo.
    Gjoni T; Desrayaud S; Imobersteg S; Urwyler S
    J Neurochem; 2006 Mar; 96(5):1416-22. PubMed ID: 16441514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.
    Urwyler S; Gjoni T; Koljatić J; Dupuis DS
    Neuropharmacology; 2005 Mar; 48(3):343-53. PubMed ID: 15721166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutations in the transmembrane region of GABAB2 facilitate activation by the positive modulator N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the absence of the GABAB1 subunit.
    Dupuis DS; Relkovic D; Lhuillier L; Mosbacher J; Kaupmann K
    Mol Pharmacol; 2006 Dec; 70(6):2027-36. PubMed ID: 16966477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats.
    Orrù A; Lai P; Lobina C; Maccioni P; Piras P; Scanu L; Froestl W; Gessa GL; Carai MA; Colombo G
    Eur J Pharmacol; 2005 Nov; 525(1-3):105-11. PubMed ID: 16289452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.
    Maccioni P; Fantini N; Froestl W; Carai MA; Gessa GL; Colombo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1558-64. PubMed ID: 18616673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA(B) receptor.
    Castelli MP; Casu A; Casti P; Lobina C; Carai MA; Colombo G; Solinas M; Giunta D; Mugnaini C; Pasquini S; Tafi A; Brogi S; Gessa GL; Corelli F
    J Pharmacol Exp Ther; 2012 Mar; 340(3):529-38. PubMed ID: 22129594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits.
    Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B
    Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911.
    Pibiri F; Carboni G; Carai MA; Gessa GL; Castelli MP
    Eur J Pharmacol; 2005 May; 515(1-3):94-8. PubMed ID: 15893746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.
    Lhuillier L; Mombereau C; Cryan JF; Kaupmann K
    Neuropsychopharmacology; 2007 Feb; 32(2):388-98. PubMed ID: 16710312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
    Schaffhauser H; Rowe BA; Morales S; Chavez-Noriega LE; Yin R; Jachec C; Rao SP; Bain G; Pinkerton AB; Vernier JM; Bristow LJ; Varney MA; Daggett LP
    Mol Pharmacol; 2003 Oct; 64(4):798-810. PubMed ID: 14500736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.
    Figler H; Olsson RA; Linden J
    Mol Pharmacol; 2003 Dec; 64(6):1557-64. PubMed ID: 14645687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site of action of the general anesthetic propofol in muscarinic M1 receptor-mediated signal transduction.
    Murasaki O; Kaibara M; Nagase Y; Mitarai S; Doi Y; Sumikawa K; Taniyama K
    J Pharmacol Exp Ther; 2003 Dec; 307(3):995-1000. PubMed ID: 14534362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of GABA B receptor subunit expression and function.
    Sands SA; McCarson KE; Enna SJ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):191-6. PubMed ID: 12649368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.